-
Product Insights
NewQuarterly Cheese pricing trends in Canada
Empower your strategies with our Quarterly Cheese pricing trends in Canada report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business choices....
-
Product Insights
NewQuarterly Cookies (Sweet Biscuits) pricing trends in Qatar
Empower your strategies with our Quarterly Cookies (Sweet Biscuits) pricing trends in Qatar report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important...
-
Product Insights
NewQuarterly Still Wine pricing trends in the United States
Empower your strategies with our Quarterly Still Wine pricing trends in the United States report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement...
-
Product Insights
NewSystemic Sclerosis (Scleroderma) – Drugs In Development, 2024
Empower your strategies with our Systemic Sclerosis (Scleroderma) – Drugs In Development, 2024 report and make more profitable business decisions. Scleroderma is a group of rare diseases that involve the hardening and tightening of the skin and connective tissues. Symptoms include muscle pain, joint pain and swelling, ulcers occurring on the fingertips, bloating, and diarrhea or constipation. Treatment includes antibiotics, pain relievers, and immunosuppressants. The Systemic Sclerosis (Scleroderma) drugs in development market research report provide comprehensive information on the therapeutics under...
-
Product Insights
NewDermatological Disorders – Drugs In Development, 2024
Empower your strategies with our Dermatological Disorders – Drugs In Development, 2024 report and make more profitable business decisions. Dermatological disorders are diseases or conditions that affect the skin, hair, or nails. They can have various causes, symptoms, and treatments. Some of the most common dermatological disorders are acne, eczema, psoriasis, rosacea, and warts. Dermatologists are doctors who specialize in diagnosing and treating these disorders. Dermatological disorders can affect the appearance, function, and quality of life of the patients. Some of...
-
Product Insights
NewEpidermolysis Bullosa – Drugs In Development, 2024
Empower your strategies with our Epidermolysis Bullosa – Drugs In Development, 2024 report and make more profitable business decisions. Epidermolysis bullosa (EB) is a group of inherited bullous disorders characterized by blister formation in response to mechanical trauma. Symptoms include blistering of skin; deformity or loss of fingernails and toenails; internal blistering including on the throat, esophagus, upper airway, stomach, intestines, and urinary tract; skin thickening on palms and soles of the feet (hyperkeratosis); and scalp blistering, scarring, and hair loss...
-
Product Insights
NewOsteogenesis Imperfecta – Drugs In Development, 2024
Empower your strategies with our Osteogenesis Imperfecta – Drugs In Development, 2024 report and make more profitable business decisions. Osteogenesis imperfecta (OI) is a genetic disorder characterized by bones that break easily, often from little or no apparent cause. This disease is caused by a defect in the gene that produces type 1 collagen, a protein used to create bone. Symptoms include bone deformities, multiple broken bones, loose joints, weak teeth, heart defects, and respiratory problems. Treatment includes bisphosphonates and surgery....
-
Product Insights
Inflammatory Disease Markers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Inflammatory Disease Markers Pipeline Market Report Overview Inflammatory Disease Markers are antigens/antibodies that detect specific antigens/antibodies produced by bone, cartilage, or any other inflammatory disease activity. The Inflammatory Disease Markers pipeline market research report provides comprehensive information about the inflammatory disease markers pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Segments ·       Anti-Cyclic Citrullinated Peptide Antibody (Anti-CCP) Analyzer Tests ·       C-Reactive Protein (CRP)...
-
Product Insights
NewNorway Still Wine market dynamics
Empower your strategies with our Norway Still Wine market dynamics report and make more profitable business decisions. Consumers' preferences for wines and spirits are most heavily influenced by novel flavors, premium ingredients, product prices, and packaging. However, manufacturers continue to launch and sell products based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Wines and spirits manufacturers can benefit from the unique intelligence provided by the GlobalData Consumer Intelligence platform, covering more than 2 million products...